Objective: To examine the validity of the family history method for id
entifying Alzheimer disease (AD) by comparing family history and neuro
pathological diagnoses. Methods: Seventy-seven former residents of the
Jewish Home and Hospital for the Aged, New York, NY, with neuropathol
ogical evaluations on record were blindly assessed for the presence of
dementia and, if present, the type of dementia through family informa
nts by telephone interviews. The Alzheimer's Disease Risk Questionnair
e was used to collect demographic information and screen for possible
dementia. If dementia was suspected, the Dementia Questionnaire was ad
ministered to assess the course and type of dementia, ie, primary prog
ressive dementia (PPD, likely AD), multiple infarct dementia, mixed de
mentia (ie, PPD and multiple infarct dementia), and other dementias ba
sed on the modified Diagnostic and Statistical Manual of Mental Disord
ers, Third Edition, criteria. Results: Sixty (77.9%) of 77 elderly sub
jects were classified as having dementia and 17 (22.1%) were without d
ementia by family history evaluation. Of the 60 elderly subjects with
dementia, 57 (95%) were found at autopsy to have had neuropathological
changes related to dementia. The sensitivity of the family history di
agnosis for dementia with related neuropathological change was 0.84 (5
7 of 68) and the specificity was 0.67 (6 of 9). Using family history i
nformation to differentiate the type of dementia, the sensitivity for
definite or probable AD (with or without another condition) was 0.69 (
36 of 51) and the specificity was 0.73 (19 of 26). The majority (9 of
15) of patients testing false negative for PPD had a history of stroke
associated with onset of memory changes, excluding a diagnosis of PPD
. Conclusions: Identifying dementia, in general, and AD, in particular
, has an acceptable sensitivity and specificity. As is true for direct
clinical diagnosis, the major issue associated with misclassifying AD
in a family history assessment is the masking effects of a coexisting
non-AD dementia or dementia-related disorders, such as stroke. Includ
ing mixed cases, ie, PPD and multiple infarct dementia in estimates of
the familial risk for AD can reduce the extent of underestimation of
PPD.